Strata Oncology Announces New Partnerships with Aurora Health Care and UTHealth
Strata Precision Oncology NetworkTM now includes 10 healthcare systems providing no-cost tumor profiling and clinical trials system-wide
ANN ARBOR, Mich., March 13, 2018 /PRNewswire/ -- Strata Oncology, a precision oncology company, today announced that Aurora Health Care, the largest healthcare system in Wisconsin, and University of Texas Health Sciences at Houston (UTHealth) have joined the Strata Precision Oncology NetworkTM (Network). Formed in 2016 by Strata Oncology, the Network is accelerating precision oncology by providing advanced cancer patients routine access to tumor profiling and matching to a portfolio of biomarker-driven pharma-sponsored clinical trials, and has since expanded to 10 healthcare systems representing more than 85,000 new cancer patients annually.
"We are excited to join a collaborative group of leading cancer centers across the country working to ensure broad, timely patient access to precision medicine," said Robert J. Amato, DO, Acting Director of the Division of Oncology at UTHealth McGovern Medical School and the Chief of the Division of Oncology at Memorial Hermann Cancer Center-TMC.
Members leverage the StrataNGSTM test, an 87-gene assay that sequences both DNA and RNA, as the foundation of comprehensive, integrated solution to deliver precision oncology system-wide. StrataNGS is available to all advanced solid tumor and lymphoma patients at no cost through the Strata Trial, a nationwide observational study providing tumor profiling and trial matching for 100,000 patients with advanced cancer.
"We welcome Aurora Health Care and UTHealth as partners committed to advancing precision oncology," said Dan Rhodes, Ph.D., CEO of Strata Oncology. "The Network continues to expand with both academic and community healthcare systems collaborating to lead the way in advancing precision medicine for cancer patients."
"This partnership reinforces our commitment to transform healthcare and deliver superior clinical outcomes," said Michael Thompson, MD, PhD, hematologist/oncologist for Aurora Cancer Care and Medical Co-Director, Oncology Precision Medicine Program at Aurora Health Care. "By partnering with Strata Oncology, Aurora Health Care will be one of a select group of health systems in the country offering advanced cancer patients increased access to precision medicine. Eligible cancer patients at Aurora Health Care will have access to tumor molecular profiling, with an opportunity to enroll on cancer clinical trials that will be available at Aurora."
The Network's additional members include:
- Christiana Care's Helen F. Graham Cancer Center & Research Institute (DE)
- Kaiser Permanente-Northern California
- Kettering Health Network (OH)
- Metro Minnesota Community Oncology Research Consortium
- Ochsner Health System (LA)
- UAB Comprehensive Cancer Center
- UNC Lineberger Comprehensive Cancer Center
- University of Wisconsin Carbone Cancer Center
About Strata Oncology
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials. The Strata Trial provides no-cost tumor sequencing to patients with advanced cancer, while offering pharmaceutical companies exclusive access to stratified patient populations to shorten clinical development timelines. Strata aims to accelerate the approval of new medicines for cancer patients by bringing together a collaborative network of key stakeholders including patients, providers and pharmaceutical companies. For more information visit www.strataoncology.com.
Media Inquiries:
Strata Oncology Media Relations
[email protected]
734-527-1000
SOURCE Strata Oncology
Share this article